إعلان
إعلان

PHIO

PHIO logo

Phio Pharmaceuticals Corp. Common Stock

1.20
USD
برعاية
+0.05
+4.52%
٠٧ يناير, ١٦:٠٠ UTC -5
مغلق
exchange

بعد الإغلاق

1.19

-0.01
-0.67%

تقارير أرباح PHIO

النسبة الإيجابية المفاجئة

PHIO تفوق 23 من 29 آخر التقديرات.

79%

التقرير التالي

بيانات التقرير القادم
٣٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.34
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
-22.73%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-60.00%

Phio Pharmaceuticals Corp. Common Stock earnings per share and revenue

On ١٣ نوفمبر ٢٠٢٥, PHIO reported earnings of -0.44 USD per share (EPS) for Q3 25, beating the estimate of -0.45 USD, resulting in a 4.14% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -9.09% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of -0.34 USD, with revenue projected to reach -- USD, implying an نقصان of -22.73% EPS, and زيادة of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
٢٦ ديسمبر ٢٠٢٥ إلى ربع سنوي4 25
تقدير
-$0.49
الفعلي
-
مفاجئة
-
الأسئلة الشائعة
For Q3 2025, Phio Pharmaceuticals Corp. Common Stock reported EPS of -$0.44, beating estimates by 4.14%, and revenue of $0.00, 0% as expectations.
The stock price moved down -9.09%, changed from $1.43 before the earnings release to $1.30 the day after.
The next earning report is scheduled for ٣٠ مارس ٢٠٢٦.
Based on 4 المحللين, Phio Pharmaceuticals Corp. Common Stock is expected to report EPS of -$0.34 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان